1. Home
  2. ALLR vs ZCMD Comparison

ALLR vs ZCMD Comparison

Compare ALLR & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • ZCMD
  • Stock Information
  • Founded
  • ALLR 2004
  • ZCMD 2012
  • Country
  • ALLR United States
  • ZCMD China
  • Employees
  • ALLR N/A
  • ZCMD N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • ZCMD Other Consumer Services
  • Sector
  • ALLR Health Care
  • ZCMD Real Estate
  • Exchange
  • ALLR Nasdaq
  • ZCMD Nasdaq
  • Market Cap
  • ALLR 20.2M
  • ZCMD 17.3M
  • IPO Year
  • ALLR N/A
  • ZCMD 2020
  • Fundamental
  • Price
  • ALLR $1.23
  • ZCMD $0.68
  • Analyst Decision
  • ALLR Strong Buy
  • ZCMD
  • Analyst Count
  • ALLR 1
  • ZCMD 0
  • Target Price
  • ALLR $9.25
  • ZCMD N/A
  • AVG Volume (30 Days)
  • ALLR 262.6K
  • ZCMD 95.0K
  • Earning Date
  • ALLR 11-14-2025
  • ZCMD 01-01-0001
  • Dividend Yield
  • ALLR N/A
  • ZCMD N/A
  • EPS Growth
  • ALLR N/A
  • ZCMD N/A
  • EPS
  • ALLR N/A
  • ZCMD N/A
  • Revenue
  • ALLR N/A
  • ZCMD $13,117,523.00
  • Revenue This Year
  • ALLR N/A
  • ZCMD N/A
  • Revenue Next Year
  • ALLR N/A
  • ZCMD N/A
  • P/E Ratio
  • ALLR N/A
  • ZCMD N/A
  • Revenue Growth
  • ALLR N/A
  • ZCMD N/A
  • 52 Week Low
  • ALLR $0.61
  • ZCMD $0.60
  • 52 Week High
  • ALLR $2.35
  • ZCMD $2.50
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 40.99
  • ZCMD 39.00
  • Support Level
  • ALLR $1.09
  • ZCMD $0.66
  • Resistance Level
  • ALLR $1.45
  • ZCMD $0.75
  • Average True Range (ATR)
  • ALLR 0.09
  • ZCMD 0.07
  • MACD
  • ALLR -0.02
  • ZCMD 0.01
  • Stochastic Oscillator
  • ALLR 37.42
  • ZCMD 47.91

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

Share on Social Networks: